BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lee HW, Ahn SH. Prediction models of hepatocellular carcinoma development in chronic hepatitis B patients. World J Gastroenterol 2016; 22(37): 8314-8321 [PMID: 27729738 DOI: 10.3748/wjg.v22.i37.8314]
URL: https://www.wjgnet.com/1007-9327/full/v22/i37/8314.htm
Number Citing Articles
1
Jiang Guo, Xue-Song Gao. Prediction models for development of hepatocellular carcinoma in chronic hepatitis B patientsWorld Journal of Clinical Cases 2021; 9(14): 3238-3251 doi: 10.12998/wjcc.v9.i14.3238
2
Mira Florea, Teodora Serban, George Razvan Tirpe, Alexandru Tirpe, Monica Lupsor-Platon. Noninvasive Assessment of Hepatitis C Virus Infected Patients Using Vibration-Controlled Transient ElastographyJournal of Clinical Medicine 2021; 10(12): 2575 doi: 10.3390/jcm10122575
3
Yuichiro Suzuki, Shinya Maekawa, Nobutoshi Komatsu, Mitsuaki Sato, Akihisa Tatsumi, Mika Miura, Shuya Matsuda, Masaru Muraoka, Natsuko Nakakuki, Hiroko Shindo, Fumitake Amemiya, Shinichi Takano, Mitsuharu Fukasawa, Yasuhiro Nakayama, Tatsuya Yamaguchi, Taisuke Inoue, Tadashi Sato, Minoru Sakamoto, Atsuya Yamashita, Kohji Moriishi, Nobuyuki Enomoto. Hepatitis B virus (HBV)‐infected patients with low hepatitis B surface antigen and high hepatitis B core‐related antigen titers have a high risk of HBV‐related hepatocellular carcinomaHepatology Research 2019; 49(1): 51 doi: 10.1111/hepr.13277
4
Aftab Ahmed, Farhan Saeed, Muhammad Umair Arshad, Muhammad Afzaal, Ali Imran, Shinawar Waseem Ali, Bushra Niaz, Awais Ahmad, Muhammad Imran. Impact of intermittent fasting on human health: an extended review of metabolic cascadesInternational Journal of Food Properties 2018; 21(1): 2700 doi: 10.1080/10942912.2018.1560312
5
Patrick Kennedy, Samuel Litwin, Grace Dolman, Antonio Bertoletti, William Mason. Immune Tolerant Chronic Hepatitis B: The Unrecognized RisksViruses 2017; 9(5): 96 doi: 10.3390/v9050096
6
Chengxiao Yu, Ci Song, Jun Lv, Meng Zhu, Canqing Yu, Yu Guo, Ling Yang, Yiping Chen, Zhengming Chen, Tao Jiang, Hongxia Ma, Guangfu Jin, Hongbing Shen, Zhibin Hu, Liming Li. Prediction and clinical utility of a liver cancer risk model in Chinese adults: A prospective cohort study of 0.5 million peopleInternational Journal of Cancer 2021; 148(12): 2924 doi: 10.1002/ijc.33487
7
Habiba Kamal, Romina Fornes, Johanna Simin, Per Stål, Ann‐Sofi Duberg, Nele Brusselaers, Soo Aleman. Risk of hepatocellular carcinoma in hepatitis B and D virus co‐infected patients: A systematic review and meta‐analysis of longitudinal studiesJournal of Viral Hepatitis 2021;  doi: 10.1111/jvh.13577
8
Yiqi Yu, Jingwen Ai, Wenhong Zhang. Current clinical evidence for nucleos(t)ide analogues in patients with HBV-related hepatocellular carcinomaExpert Review of Gastroenterology & Hepatology 2017; 11(10): 925 doi: 10.1080/17474124.2017.1343665
9
Barbora Lubyova, Jan Hodek, Ales Zabransky, Hana Prouzova, Martin Hubalek, Ivan Hirsch, Jan Weber, Haitao Guo. PRMT5: A novel regulator of Hepatitis B virus replication and an arginine methylase of HBV corePLOS ONE 2017; 12(10): e0186982 doi: 10.1371/journal.pone.0186982
10
Chansik An, Jong Won Choi, Hyung Soon Lee, Hyunsun Lim, Seok Jong Ryu, Jung Hyun Chang, Hyun Cheol Oh. Prediction of the risk of developing hepatocellular carcinoma in health screening examinees: a Korean cohort studyBMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08498-w
11
Yinghua Zhang, Chuanfang Wang, Hui Li, Yuanyuan Ding. Decreased liver stiffness by transient elastography indicates lower incidence of hepatocellular carcinoma in patients with chronic hepatitis BMedicine 2019; 98(3): e13929 doi: 10.1097/MD.0000000000013929
12
Isabelle Beaudry-Bellefeuille, Alison Lane, Simon Chiu, Christopher Oldmeadow, Eduardo Ramos Polo, Shelly J Lane. The Toileting Habit Profile Questionnaire-Revised: Examining Discriminative and Concurrent ValidityJournal of Occupational Therapy, Schools, & Early Intervention 2019; 12(3): 311 doi: 10.1080/19411243.2019.1590756
13
Hye Won Lee, Sang Hoon Ahn, Henry Lik-Yuen Chan. Hepatitis B Core-Related Antigen: From Virology to Clinical ApplicationSeminars in Liver Disease 2021; 41(02): 182 doi: 10.1055/s-0041-1723088
14
Li Zhao, Qian Yang, Jianbo Liu. Clinical Value Evaluation of microRNA-324-3p and Other Available Biomarkers in Patients With HBV Infection–Related Hepatocellular CarcinomaOpen Forum Infectious Diseases 2021; 8(6) doi: 10.1093/ofid/ofab108
15
Ahmed Wahid, Mustafa A. Hamzawy, Mohamad M. A. Khalifa, Gamal F. M. Gad, Amany Bekhit, Sayed F. Abdelwahab. RNA protein kinase SNP at −226 C<T is a biomarker for the clearance of HCV among Egyptian patientsImmunological Investigations 2019; 48(3): 211 doi: 10.1080/08820139.2018.1493496
16
An K Le, Hwai-I Yang, Ming-Lun Yeh, Mingjuan Jin, Huy N Trinh, Linda Henry, Anne Liu, Jian Q Zhang, Jiayi Li, Christopher Wong, Clifford Wong, Ramsey Cheung, Ming-Lung Yu, Mindie H Nguyen. Development and Validation of a Risk Score for Liver Cirrhosis Prediction in Untreated and Treated Chronic Hepatitis BThe Journal of Infectious Diseases 2021; 223(1): 139 doi: 10.1093/infdis/jiaa330
17
Monica Lupsor-Platon, Teodora Serban, Alexandra-Iulia Silion, Alexandru Tirpe, Mira Florea. Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease: A Step Forward for Better Evaluation Using Ultrasound ElastographyCancers 2020; 12(10): 2778 doi: 10.3390/cancers12102778
18
Mayuko Nishi, Kei Miyakawa, Satoko Matsunaga, Hajera Khatun, Yutaro Yamaoka, Koichi Watashi, Masaya Sugiyama, Hirokazu Kimura, Takaji Wakita, Akihide Ryo. Prolyl Isomerase Pin1 Regulates the Stability of Hepatitis B Virus Core ProteinFrontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.00026
19
Grace Lai-Hung Wong. Liver Elastography2020; : 375 doi: 10.1007/978-3-030-40542-7_34
20
Tung-Hung Su, Jia-Horng Kao. Unmet Needs in Clinical and Basic Hepatitis B Virus ResearchThe Journal of Infectious Diseases 2017; 216(suppl_8): S750 doi: 10.1093/infdis/jix382
21
Luca Rinaldi, Antonio Ascione, Vincenzo Messina, Valerio Rosato, Giovanna Valente, Vincenzo Sangiovanni, Rosa Zampino, Aldo Marrone, Luca Fontanella, Nicolina de Rosa, Pasquale Orabona, Carmela Buonomo, Antonio Chirianni, Luigi Elio Adinolfi, Guido Piai. Influence of antiviral therapy on the liver stiffness in chronic HBV hepatitisInfection 2018; 46(2): 231 doi: 10.1007/s15010-017-1113-1
22
Bao-Min Shi, Wen Lu, Kun Ji, Yu-Feng Wang, Shuai Xiao, Xiu-Yan Wang. Study on the value of serum miR-106b for the early diagnosis of hepatocellular carcinomaWorld Journal of Gastroenterology 2017; 23(20): 3713-3720 doi: 10.3748/wjg.v23.i20.3713
23
Tony Stankus. Reviews of Science for Science Librarians: Low-FODMAP Diets for Irritable Bowel Syndrome and Related DisordersScience & Technology Libraries 2019; 38(3): 243 doi: 10.1080/0194262X.2019.1617226
24
Derek J. Erstad, Bryan C. Fuchs, Kenneth K. Tanabe. Molecular signatures in hepatocellular carcinoma: A step toward rationally designed cancer therapyCancer 2018; 124(15): 3084 doi: 10.1002/cncr.31257
25
Haneulsaem Shin, Yeon Woo Jung, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Yeun-Yoon Kim, Jin-Young Choi, Seung Up Kim. Risk assessment of hepatocellular carcinoma development for indeterminate hepatic nodules in patients with chronic hepatitis BClinical and Molecular Hepatology 2019; 25(4): 390 doi: 10.3350/cmh.2018.0103
26
Jung Woo Shin, Joonho Jeong, Seok Won Jung, Seung Bum Lee, Bo Ryung Park, Min-Ju Kim, Eun Ji Park, Neung Hwa Park. Comparable Incidence of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Entecavir or TenofovirDigestive Diseases and Sciences 2021; 66(5): 1739 doi: 10.1007/s10620-020-06375-3
27
Yeon Seok Seo, Byoung Kuk Jang, Soon Ho Um, Jae Seok Hwang, Kwang-Hyub Han, Sang Gyune Kim, Kwan Sik Lee, Seung Up Kim, Young Seok Kim, Jung Il Lee. Validation of risk prediction models for the development of HBV-related HCC: a retrospective multi-center 10-year follow-up cohort studyOncotarget 2017; 8(68): 113213 doi: 10.18632/oncotarget.22375
28
Ching-Chung Lin, Ming-Jong Bair, Chia-Yuan Liu, Ze-Yu Lin, Chih-Jen Chen, Ming-Jen Chen, Cheng-Hsin Chu, Horng-Yuan Wang, Shou-Chuan Shih, Tsang-En Wang. High percentage atypical hepatocellular carcinoma in chronic hepatitis B patients treated with nucleos(t)ide analogsMedicine 2019; 98(1): e13818 doi: 10.1097/MD.0000000000013818
29
Xiang Cui, Xiaoyan Jiang, Chunshan Wei, Yufeng Xing, Guangdong Tong. Astragaloside IV suppresses development of hepatocellular carcinoma by regulating miR-150-5p/β-catenin axisEnvironmental Toxicology and Pharmacology 2020; 78: 103397 doi: 10.1016/j.etap.2020.103397